HCPCS Level II · Drugs administered other than oral method
J1300Injection, eculizumab, 10 mg
Terminated 03/31/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1300
J1300 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, eculizumab, 10 mg.
It was added to HCPCS effective 01/01/2008, and its current record took effect 04/01/2025.
It was terminated on 03/31/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Eculizumab injection
- Date added
- 01/01/2008
- Action effective
- 04/01/2025
- Termination date
- 03/31/2025
- BETOS
- O1E
Related J13xx codes
- J1301Injection, edaravone, 1 mg
- J1302Injection, sutimlimab-jome, 10 mg
- J1303Injection, ravulizumab-cwvz, 10 mg
- J1304Injection, tofersen, 1 mg
- J1305Injection, evinacumab-dgnb, 5mg
- J1306Injection, inclisiran, 1 mg
- J1307Injection, crovalimab-akkz, 10 mg
- J1308Injection, famotidine, 0.25 mg
- J1320Injection, amitriptyline hcl, up to 20 mg
- J1322Injection, elosulfase alfa, 1 mg
- J1323Injection, elranatamab-bcmm, 1 mg
- J1324Injection, enfuvirtide, 1 mg
Common questions about J1300
Is HCPCS J1300 still valid?
- No. J1300 was terminated on 03/31/2025.
Does Medicare cover J1300?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.